Hydromorph Contin · DIN 02125323 · 3 mg · CR capsule
General benefitMarketed · checked November 18, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
No interchangeable product listed in the Ontario extract
Hydromorph Contin · DIN 02125323
Manufacturer: Purdue Pharma; listing date 1998-12-31
Health Canada: Marketed since 1995-12-31 · brand HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG · ATC N02AA03 HYDROMORPHONE · form Capsule (sustained-release) · route Oral · ingredients HYDROMORPHONE HYDROCHLORIDE 3 MG · company Purdue pharma · schedule Narcotics (cdsa i)
Hydromorph Contin: Formulary list price $0.81 per unit (the source does not state the unit; exact figure $0.8080). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02125323)
Source record
DIN 02125323: Hydromorph Contin
Raw flags: sec3=Y
Item: 280808097; group id 406; item number 0969; lccId None; manufacturer id PFP
Source form: CR Cap; strength: 3mg
Recorded listing: General benefit
Source prices (unrounded): $0.8080; ministry $0.8080
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02125323
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=18556
Shortage status: not checked (no credentials)